Mankind Pharma Limited IPO Message Board (Page 58)

Ye ipo to listing ke baad doob jayega
Very overpriced
Huge borrowings
Complete OFS will list at negative
My prediction for USK and Avalon teg was perfectly right
This time it will also be right

100% agree with u.. People who will apply in it are taking big gamble with their money. It should tarde at atleast 30-40% discount to its ipo price after 6 months like what happened to lic which was another overhyped ipo

Erise life science
Glenmark
Gland phrama
Sab issue price se niche chal rha hai

Factually wrong. Eris and Gland price was over IPO price for long time

Gland is much better than buy at cmp then applying in this ipo.

@Admin @ Chittorgarh.com 
Please see price band ad in Financial Express today. it gives issue dates which are official as they can be

Price Band is very High because 1 Rs Face value.
Company is good but valuation is High therefore public see only tailor not picture.

High compared to what? Please share name of company with similar performance and cheaper price

100% OFS ???

Mankind Pharma IPO – Schedule *(FINAL – Pg. 520 of RHP)*

20th April – Announcement of Price Band
24th April – Anchor Investors Allotment
25th April – Offer Opens
27th April – Offer Closes
03rd May – Finalisation of Basis of Allotment
04th May – Unblocking of funds from ASBA Account
08th May – Credit of Equity Shares to Demat accounts
09th May – Commencement of Trading
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – Issue Information *(FINAL)*

Issue Opens on: 25th April 2023
Issue Closes on: 27th April 2023
Issue Type: Book Built Issue IPO
Issue Size: 4,00,58,844 Shares
Face Value: Re.1/- per Share
Issue Price: Rs.1,026 – Rs.1,080 Share
Discount: NIL
Market Lot: 13 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 40,05,88,440 Shares
Fresh Issue of NIL Shares @1,080/- = Rs.NIL Crs
Offer for Sale of 4,00,58,844 Shares @1,080/- = Rs.4,326.36Crs
Equity Shares outstanding after the Issue = 40,05,88,440 Shares

Category-wise Break up:
Anchor – 1,20,17,263 Shares = 1,297.91Crs
QIB – 80,11,769 Shares = 865.27Crs
B-NII (>10L) – 40,05,885 Shares = 432.64Crs (Lot size: 936 = 4,280 Forms)
S-NII (2L-10L) – 20,02,942 Shares = 216.32Crs (Max Lot size: 195 = 10,271 Forms)
RII (<2L) – 1,40,20,595 Shares = 1514.22Crs (Max Lot size: 13 = 10,78,507 Forms)
Total Issue – 4,00,58,844 Shares = 4,326.36Crs.
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – Financial Information (Basis of Valuation)

The information is collated from the following documents:
1) RHP = Red Herring Prospectus Dated April 14,2023 (588 pages)

EPS for FY19-20 >>> Rs.25.72 (Page #140 of RHP)
EPS for FY20-21 >>> Rs.31.59 (Page #140 of RHP)
EPS for FY21-22 >>> Rs.35.78 (Page #140 of RHP)
EPS for 9M21-22 >>> Rs.31.04 (Page #140 of RHP)
*EPS for 9M22-23 >>> Rs.24.87 (Page #140 of RHP)*

RoNW for FY19-20 >>> 29.56% (Page #141 of RHP)
RoNW for FY20-21 >>> 26.80% (Page #141 of RHP)
RoNW for FY21-22 >>> 23.29% (Page #141 of RHP)
RoNW for 9M21-22 >>> 20.84% (Page #141 of RHP)
*RoNW for 9M22-23 >>> 13.94% (Page #141 of RHP)*

NAV as on 31st December 2022, was Rs.178.38 (Page #141 of RHP)

Listed Industry Peer Group (Page #144 of RHP): Sun Pharmaceuticals Industries, Cipla, Zydus Lifesciences, Torrent Pharmaceutical, Alkem, JB Chemicals & Pharmaceuticals, Eris Lifesciences, Ipca Laboratories, Abbott India, Glaxosmithkline Pharmaceuticals, Dabur India, Procter & Gamble Health, Zydus Wellness
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – *Required for 1X Subscription*:

Anchor = 1,297.91Crs
QIB = 865.27Crs

B-NII (>10L) Application = 20,543 Forms (for lotsize of 195)
S-NII (2L-10L) Application = 10,271 Forms (for lotsize of 195)
RII (<2L) Application = 10,78,507 Forms (for lotsize of 13)
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – *Market’s Current Estimates of OverSubscription*:

QIB = 40KCrs. = ~46.23X

B-NII (>10L) = 50K Forms = 2.43X Applic. wise (Avg allotment ~80.12 shares)

S-NII (2L-10L) = 75K Forms = 7.30X Applic. wise (Avg allotment ~26.71 shares)

RII (<2L) Application = 18L Forms = 1.67X Applic. wise (Avg allotment ~7.79 shares)
_______________________________________________________________________________________________________________________________

Interest cost *@9.00%p.a.* for 7days = *186.41paise for 1X*

Thus,
for QIB the costing = 46.23 X 186.41 paise = Rs.86.17 per share (= GMP)

for B-NII (>10L) the costing = 80.12 X 86.17 = Rs.6,904 per form

for S-NII (2L-10L) the costing = 26.71 X 86.17 = Rs.2,301 per form

And, for RII (<2L) the costing = 7.79 X 86.17 = Rs.671 (= Kostak)
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – *GMP Estimated* (as on 18/April EOD)

GMP = 85 +/- 2

KOSTAK
for B-NII (>10L) = 6,750/-
for S-NII (2L-10L) = 2,250/-
for RII (<2L) = 650/-

SUBJECT TO ALLOTMENT:
for NII (>2L) (for lotsize of 195) = 14,000/-
for RII (<2L) (for lotsize of 13) = 940/-
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO

*HOS* Expected for FY23-24:

PAT = 1,925Crs
& EPS = 48.05

Therefore,
Forward P/E = 22.50X (if issue price = 1,080)
_______________________________________________________________________________________________________________________________

Mankind Pharma IPO – *Expected Delivery Volume on Listing Day*

Pre-opening = 56.00L shares (NSE + BSE)
EOD = 225.00L shares (NSE + BSE)

Any changes to subscription estimates? Increased/decreased?

Hello mam
Been a while since you posted , but really good to see you back, Mankind looka good enough to hold for a while.
Been a fan since a long time esp the ipo run of 17-18

80/85 GMP last heard just a few seconds ago!

Mankind Pharma IPO – *GMP Estimated* (as on 18/April EOD)

GMP = 85 +/- 2

KOSTAK
for B-NII (>10L) = 6,750/-
for S-NII (2L-10L) = 2,250/-
for RII (<2L) = 650/-

SUBJECT TO ALLOTMENT:
for NII (>2L) (for lotsize of 195) = 14,000/-
for RII (<2L) (for lotsize of 13) = 940/-

Mankind Pharma Limited IPO Final Details:

Date : 25 - 27 Apr,2023
Price : ₹1026 - ₹1080
Market Lot : 13 Shares
Appl Amt : ₹14,040
Size : ₹4,326.36 Cr Approx
Retail Portion : 35%
Face Value : ₹1
Retail Form : 10,78,500 Approx
HNI Small Form : 10,270 Approx
HNI Big Form : 20,540 Approx

Bidding details

Mankind Final Details.

Date 25/04 to 27/04
PB 1026 - 1080
Lot 13 Share

Retail - 13 share - 14040/-
No. Of Forms : 10,78,507

SHNI - 195 Share - 210600/-
No. Of forms 10,271

BHNI - 936 Share - 1010880/-
No. Of forms 20,543 ( for 1 Lot of 195 )

Avalon ko capital mkt ne 51/100 ka sabse majboot fundamental ka rating diya tha vohi issue price se 10% down close hua ,
Abhi main line ipo mai retailor ko nuksan ke alwava kuch nhi mil rha

Issue Final
Date :- 23-25
Price band :- 1026 - 1080
Lot Size :- 3 share
Listing :- 8 May
Register :- Kfintech

@MAMU 
Wrong lot size

I posted reply in comment section, somehow its deleted by admin. May be due to seems like duplicate message.

Lot Size :- 13

Corrected already
And sorry for misplace nos by mistake.

Ipo rates not yet finalized but GMP market opened. Without knowing the rate , how can the GMP rates be justified or believed. GMP May be just gimmick , just for garnering subscription from retail

dont know if people have too much surplus money or they just want to gamble on anything. how can anybody apply at such expensive valuations when many decent companies in sector trading at much cheaper valuations

Terrible comparison. Sanofi is a huge dividend paying company. That's why its share price is always compressed (as a result of which it has a low PE ratio). Gland is an injectable manufacturer and not a consumer healthcare or OTC player. It has been reporting lower revenues/profits for several quarters now and its guidance for the next year is also terrible. Besides, Gland's Chinese parent is in deep financial trouble and looking to sell off Gland.

The real comparable peers for Mankind are Sun Pharma, Cipla, Torrent and Abbott. Mankind's PE ratio is fair for this segment.

@Abhijeet Kumar Gland Pharma's Q4 result shows why it was trading at a low PE. Market is forward-looking. Don't buy stocks just because the PE ratio is low. Most of the low PE stocks are just "value traps".

Mankind IPO date April 25 to April 27

Looking to various comments by learned persons I just want to add whatever be the situation always sail boat in same direction. I.e. if one always sell ipo stock on Allotment then one should follow the same strategy or keep on hold then keep holding but apply only very good company with a stop loss.
I generally used to sell all allotted shares on the day of listing itself and easily earn handsome return of 18 to 24 % of the money earmarked for ipo purpose at the end of year.
I use this strategy since last 30 years .
For newcomers take risk that suits to them but my suggestion is first make some corpus of profit from ipo then take a little risk only.

@PLAZA 
Good to read that you are investing for more than 30 years. When I read your title PLAZA, I just remembering my old days of Delhi and the cinema hall named PLAZA in Connaught Place.
In my post dated 21.03.23 in USK I have said the same thing FOLLOW ONE PATTERN, either book listing gains or keep it for long, but keep reviewing. Don't allow the shares tobe like PayTM or Car Trade.
One more thing when you follow any person, follow him in full and not as per own convenience. Never blame others for the decision taken by self.
Have a nice time and health.

@pkraj.
Absolute right sir .
Thanks for your good wishes .
One should not be greedy in this market .

वो कहते है की आज अगर शेयर बेचेंगे तो मावे की kachori kha सकते है कल का पत्ता नहीं तेल की kachori भी मिलेंगी की नहीं.
Have a good day to all

Why admin, yet to update dates of Mankind IPO ???

@Earthking 
The dates will be announced tomorrow at around 1 PM.

86/90 last heard GMP…

Abhi bahot time se GMP dalna kar Diya hai apne

M I right or wrong???

Ji bhai. Logon ke 100 sawal ke jawab kaun de.. ki Jaipur me ye bhav hai, Rajkot me ye hai.. etc etc. isliye jab kaphi time tak koi nahii daalta tab main daal deta hoon.. 😊

FIRM ALLOTMENT CONFIRM.

Shayad retail me allotment mil jaye
Majhe Lagta he ki subscription figures bohot acchhe aane vale he atleast 4x

my personal prediction is

if valuation is not ok...(so much less then tentative price rs 1060-1080)

then this ipo will not even full subscribe in Retail nd Shni....